Acer Therapeutics Inc Warrant
ACERW
ACERW was delisted on the 5th of April, 2018.
0 hedge funds and large institutions have $0 invested in Acer Therapeutics Inc Warrant in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $6K → $0 (-$6K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3K |
| 2 |
Bank of New York Mellon
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$3K | -1,001,125 | Closed |
|
|
2
Bank of New York Mellon
New York
| – | -$1K | -305,425 | Closed |
|
ACERW Hedge Fund Activity: Q2 2018 in Review
0 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Acer Therapeutics Inc Warrant (ACERW) for Q2 2018, worth a combined $0 — down 100% from $6K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ACERW and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $3K sold.
- 0 institutional investors held Acer Therapeutics Inc Warrant (ACERW) as of Q2 2018, down from 4 in Q1 2018.
- Funds reported $0 of Acer Therapeutics Inc Warrant stock for Q2 2018, down 100% quarter-over-quarter.
- 0 funds opened new Acer Therapeutics Inc Warrant positions in Q2 2018 and 4 closed out, a net change of -4 holders.
- The largest Acer Therapeutics Inc Warrant seller in Q2 2018 was Susquehanna International Group, an estimated $3K sold.
Based on aggregated 13F filings for Q2 2018.